Tmunity Overview
- Year Founded
-
2009
- Status
-
Acquired/Merged
- Employees
-
27
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$1.3B
- Investors
-
2
Tmunity General Information
Description
Operator of a next-generation immunotherapies development company intended to deliver cell immunotherapy to patients to treat a wide range of disease indications. The company specializes in developing novel cell receptors and engineered T-cell platforms that exhibit control over T-cell activation and direction as well as proprietary technologies to activate, expand, and genetically engineer T-cells from peripheral blood, cord blood, and tumors, thereby enabling physicians to progress in the treatment of oncology, infectious diseases, and autoimmune diseases.
Contact Information
Website
www.tmunity.comCorporate Office
- 3020 Market Street
- Suite 535
- Philadelphia, PA 19104
- United States
Corporate Office
- 3020 Market Street
- Suite 535
- Philadelphia, PA 19104
- United States
Tmunity Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Merger/Acquisition | 22-Feb-2023 | $1.3B | Completed | Generating Revenue | ||
| 4. Early Stage VC (Series B) | 30-Oct-2019 | Completed | Generating Revenue | |||
| 3. Early Stage VC (Series A) | 01-Apr-2018 | Completed | Generating Revenue | |||
| 2. Seed Round | 12-Jan-2016 | $10M | $10M | Completed | Generating Revenue | |
| 1. University Spin-Out | 01-Jan-2009 | Completed | Startup |
Tmunity Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | ||||||||
| Series A | ||||||||
| Seed | 1,968,007 | $0.000100 | 6% | $4.41 | $4.41 | 1x | $4.41 | 4.78% |
Tmunity Comparisons
Industry
Financing
Details
Tmunity Competitors (31)
One of Tmunity’s 31 competitors is Marengo Therapeutics, a Venture Capital-Backed company based in Cambridge, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Marengo Therapeutics | Venture Capital-Backed | Cambridge, MA | ||||
| Cellaion | Formerly VC-backed | Mont-Saint-Guibert, Belgium | ||||
| Centrose | Venture Capital-Backed | Madison, WI | ||||
| Adaptimmune Therapeutics | Formerly VC-backed | Abingdon, United Kingdom | ||||
| Lisata Therapeutics | Corporation | Basking Ridge, NJ |
Tmunity Patents
Tmunity Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20240123068-A1 | Cd19 binders, car-t constructs comprising the same, and methods of using the same | Pending | 18-Oct-2022 | ||
| US-20230190809-A1 | Alternative generation of allogeneic human t cells | Pending | 10-Sep-2021 | ||
| WO-2023039041-A1 | Alternative generation of allogeneic human t cells | Inactive | 10-Sep-2021 | ||
| WO-2023009412-A1 | Dnvsig3 and dnvsig8 receptors and methods of using the same | Inactive | 26-Jul-2021 | ||
| AU-2021332334-A1 | Vector-free process for manufacture of engineered immune cells | Pending | 27-Aug-2020 | C12N5/0636 |
Tmunity Signals
Tmunity Former Investors (12)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| ACS BrightEdge | Corporate Venture Capital | Minority | ||
| Andreessen Horowitz | Venture Capital | Minority | ||
| Cultural Leadership Fund | Venture Capital | Minority | ||
| Kleiner Perkins | Venture Capital | Minority | ||
| LAV (Lilly Asia Fund) | Corporate Venture Capital | Minority |
Tmunity FAQs
-
When was Tmunity founded?
Tmunity was founded in 2009.
-
Where is Tmunity headquartered?
Tmunity is headquartered in Philadelphia, PA.
-
What is the size of Tmunity?
Tmunity has 27 total employees.
-
What industry is Tmunity in?
Tmunity’s primary industry is Biotechnology.
-
Is Tmunity a private or public company?
Tmunity is a Private company.
-
What is the current valuation of Tmunity?
The current valuation of Tmunity is .
-
What is Tmunity’s current revenue?
The current revenue for Tmunity is .
-
How much funding has Tmunity raised over time?
Tmunity has raised $220M.
-
Who are Tmunity’s investors?
ACS BrightEdge, Andreessen Horowitz, Cultural Leadership Fund, Kleiner Perkins, and LAV (Lilly Asia Fund) are 5 of 12 investors who have invested in Tmunity.
-
Who are Tmunity’s competitors?
Marengo Therapeutics, Cellaion, Centrose, Adaptimmune Therapeutics, and Lisata Therapeutics are some of the 31 competitors of Tmunity.
-
When was Tmunity acquired?
Tmunity was acquired on 22-Feb-2023.
-
Who acquired Tmunity?
Tmunity was acquired by Kite Pharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process